There are currently no headlines for this stock.
BriaCell is a breast cancer immunotherapy biotech which has developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. Thevaccine has demonstrated highly encouraging Phase-I safety and efficacy data in patients with advanced breast cancers.
Sector: Basic Materials
Industry: Steel & Iron
Country: United States
Other News & PR